First-line anaplastic lymphoma kinase (Alk) inhibitors for alk-positive lung cancer in asian populations: Systematic review and network meta-analysis

Wu K.-L.Chen H.-L.Tsai Y.-M.Lee T.-H.Chang H.-M.Tsai Y.-C.Chuang C.-H.Chang Y.-C.YU-KANG TUYang C.-J.Hung J.-Y.Chong I.-W.2022-05-102022-05-1020212077-0383https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115737371&doi=10.3390%2fjcm10194376&partnerID=40&md5=9700f8d4d0653f306b6491d685fe4f1chttps://scholars.lib.ntu.edu.tw/handle/123456789/610088[SDGs]SDG3First-line anaplastic lymphoma kinase (Alk) inhibitors for alk-positive lung cancer in asian populations: Systematic review and network meta-analysisreview10.3390/jcm101943762-s2.0-85115737371